|
|
| Line 12: |
Line 12: |
| *[[Diabetes mellitus]] | | *[[Diabetes mellitus]] |
| *[[Obesity]] | | *[[Obesity]] |
|
| |
| ===Primary hypertriglyceridemia===
| |
| ====Genetics <ref name="pmid19355858">{{cite journal| author=Kolovou GD, Anagnostopoulou KK, Kostakou PM, Bilianou H, Mikhailidis DP| title=Primary and secondary hypertriglyceridaemia. | journal=Curr Drug Targets | year= 2009 | volume= 10 | issue= 4 | pages= 336-43 | pmid=19355858 | doi= | pmc= | url= }} </ref>====
| |
| =====Type I hyperlipoproteinemia=====
| |
| * [[Genetic]] deficiency or dysfunction of enzyme [[lipoprotein lipase]] (LPL)
| |
| * Deficiency of apo C-II, that acts as a cofactor of [[LPL]]
| |
| * Insulin deficiency or dysfunction in [[diabetes]] type 1 and 2 can also cause this disorder as LPL requires insulin for its full function.
| |
| =====Familial combined hyperlipidemia=====
| |
| * [[Autosomal dominant]] disorder
| |
| * Patients have either isolated [[triglyceride]] or LDL-c elevations or both.
| |
| * Family history of premature [[coronary artery disease]] in 1 or more first-degree relatives
| |
| * Family history for elevated triglycerides with or without elevated LDL-c levels.
| |
| =====Familial hypertriglyceridemia=====
| |
| * Autosomal dominant trait
| |
| * These patients and their families have isolated triglyceride elevations
| |
| * Increased risk of premature coronary artery disease.
| |
| ===Idiopathic (constitutional)===
| |
| ===Secondary hypertriglyceridemia===
| |
| ===Metabolic <ref name="pmid19355858">{{cite journal| author=Kolovou GD, Anagnostopoulou KK, Kostakou PM, Bilianou H, Mikhailidis DP| title=Primary and secondary hypertriglyceridaemia. | journal=Curr Drug Targets | year= 2009 | volume= 10 | issue= 4 | pages= 336-43 | pmid=19355858 | doi= | pmc= | url= }} </ref>===
| |
| * [[Diabetes mellitus]] and [[insulin resistance]]
| |
| * [[Obesity]]
| |
| * [[Hypothyroidism]]
| |
| * [[Nephrotic syndrome]]
| |
| * [[Renal failure]]
| |
| ===Drugs===
| |
| * [[Diuretics]] (high dose [[thiazide]] or [[chlorthalidone]])
| |
| * [[Beta-blockers]] (high doses)
| |
| * [[Estrogen replacement therapy]]
| |
| * [[Oral contraceptive pills]] (high [[estrogen]] )
| |
| * [[Tamoxifen]]
| |
| * [[Glucocorticoids]]
| |
| * Oral [[isotretinoin]]
| |
| * [[Antiretroviral therapy]] ([[protease inhibitors]], [[nonnucleoside reverse transcriptase inhibitors]])
| |
| * Atypical [[antipsychotics]]
| |
| ===Miscellaneous===
| |
| * [[Alcohol]]
| |
| * [[Pregnancy]]
| |
| * [[Acute pancreatitis]]
| |
| * [[Nonalcoholic fatty liver]] disorder
| |
| * High-carbohydrate or [[high glycemic index]]
| |
| * [[Glycogen storage disease]] type 1
| |
| * [[Lysosomal acid lipase deficiency]] or [[Cholesteryl ester storage disease]]
| |
| * [[Paraproteinemia]]s (e.g., [[hypergammaglobulinemia]] in [[macroglobulinemia]], [[myeloma]], [[lymphoma]] and [[lymphocytic leukemias]])
| |
| * [[Autoimmune]] disorders (e.g., [[systemic lupus erythematosis]])
| |
|
| |
|
| ==References== | | ==References== |